We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Skyworks Solutions
SWKS
$10.1B
| $246K | ﹤0.01% |
+2,506
| New | +$214K |
|
502
Allstate
ALL
$65.1B
| $243K | ﹤0.01% |
3,417
+53
| +2% | +$3.74K |
|
|
SINA
503
DELISTED
Sina Corp
SINA
| $243K | ﹤0.01% |
7,559
+575
| +8% | +$20.7K |
|
|
CB
504
DELISTED
CHUBB CORPORATION
CB
| $242K | ﹤0.01% |
2,395
-310
| -11% | -$31.4K |
|
505
Target
TGT
$75.4B
| $241K | ﹤0.01% |
2,938
-17
| -0.6% | -$1.31K |
|
506
British American Tobacco
BTI
$121B
| $238K | ﹤0.01% |
4,590
+330
| +8% | +$18.3K |
|
|
HSEA.CL
507
DELISTED
HSBC Holdings plc
HSEA.CL
| $236K | ﹤0.01% |
9,000
| – | – |
|
|
OKS
508
DELISTED
Oneok Partners LP
OKS
| $234K | ﹤0.01% |
5,730
-385
| -6% | -$16.1K |
|
509
Eaton
ETN
$162B
| $232K | ﹤0.01% |
3,411
-200
| -6% | -$13.6K |
|
510
Ares Capital
ARCC
$14.3B
| $231K | ﹤0.01% |
13,481
-5,054
| -27% | -$84.4K |
|
511
Universal Display
OLED
$3.9B
| $231K | ﹤0.01% |
+4,935
| New | +$175K |
|
512
Fortinet
FTNT
$127B
| $228K | ﹤0.01% |
+32,555
| New | +$212K |
|
|
RDS.A
513
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $228K | ﹤0.01% |
4,083
+371
| +10% | +$22K |
|
|
VAR
514
DELISTED
Varian Medical Systems, Inc.
VAR
| $228K | ﹤0.01% |
2,761
+12
| +0.4% | +$963 |
|
515
Sysco
SYY
$39.5B
| $227K | ﹤0.01% |
6,024
+668
| +12% | +$26.3K |
|
516
TE Connectivity
TEL
$58.8B
| $226K | ﹤0.01% |
+3,160
| New | +$217K |
|
517
Omnicell
OMCL
$1.52B
| $222K | ﹤0.01% |
6,333
-1,309
| -17% | -$43.2K |
|
518
Gaming and Leisure Properties
GLPI
$12.3B
| $221K | ﹤0.01% |
+6,000
| New | +$203K |
|
519
Occidental Petroleum
OXY
$59.1B
| $220K | ﹤0.01% |
3,016
-554
| -16% | -$42.8K |
|
520
Workday
WDAY
$47.8B
| $219K | ﹤0.01% |
2,595
-379
| -13% | -$32K |
|
521
Bausch Health
BHC
$2.36B
| $218K | ﹤0.01% |
+1,100
| New | +$195K |
|
522
ProShares Ultra Financials
UYG
$840M
| $218K | ﹤0.01% |
9,000
| – | – |
|
523
American Express
AXP
$226B
| $215K | ﹤0.01% |
2,755
-1,440
| -34% | -$120K |
|
524
Celldex Therapeutics
CLDX
$3.18B
| $214K | ﹤0.01% |
+512
| New | +$183K |
|
|
GNMK
525
DELISTED
GenMark Diagnostics, Inc
GNMK
| $214K | ﹤0.01% |
16,489
+2,843
| +21% | +$37.2K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.